Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obesity
  Free Subscription

Articles published in
BMJ
    August 2026
  1. O'DOWD A
    Obesity numbers in England double in 30 years despite 14 government strategies.
    BMJ. 2026;394:e100531.
    >> Share

  2. BROWN C
    Retatrutide: Obesity drug opens to "compassionate use" in US after speculation Trump took it.
    BMJ. 2026;394:e100530.
    >> Share

    July 2026
  3. WATSON MC, Neil KE
    Mandatory, standardised food labelling should be just one element of a multifaceted campaign against obesity.
    BMJ. 2026;394:e100354.
    >> Share

  4. GASOYAN H, Rothberg MB
    Comparing benefits and harms of obesity drugs.
    BMJ. 2026;394:e725349.
    >> Share

  5. NONG K, Shi Q, Xie X, Wang Y, et al
    Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.
    BMJ. 2026;394:e372161.
    >> Share

  6. TORJESEN I
    Most obesity drugs do not improve quality of life or reduce cardiovascular risk, analysis finds.
    BMJ. 2026;394:e100232.
    >> Share

    June 2026
  7. WISE J
    Obesity is rising fastest in young adults, study shows.
    BMJ. 2026;393:e100097.
    >> Share

  8. MURPHY F
    Obesity versus China: how Ozempic is complicating the world's largest weight loss campaign.
    BMJ. 2026;393:e523232.
    >> Share

  9. VOGEL C
    A single, mandatory warning label on unhealthy foods is key to a joined-up approach to obesity.
    BMJ. 2026;393:e288249.
    >> Share

    May 2026
  10. MAHASE E
    Obesity, weight loss drugs, and art: why Picasso would have painted "GLP-1 face".
    BMJ. 2026;393:e515080.
    >> Share

    April 2026
  11. KOPITOWSKI K, Franco JVA
    Weight "regain" in obesity shifts responsibility from biology to personal inadequacy.
    BMJ. 2026;393:s648.
    >> Share

    March 2026
  12. BUSE K, Carriedo A, Barquera S
    Treatment with GLP-1 drugs must not replace obesity prevention in low and middle income countries.
    BMJ. 2026;392:s407.
    >> Share

    February 2026
  13. WISE J
    Obesity: One in 10 infectious disease deaths linked to condition, study shows.
    BMJ. 2026;392:s263.
    >> Share

    January 2026
  14. WILKINSON E
    Child obesity: McDonald's drive-through plan rejected by Sheffield Council on health grounds.
    BMJ. 2026;392:s130.
    >> Share

  15. WEST S, Scragg J, Aveyard P, Oke JL, et al
    Weight regain after cessation of medication for weight management: systematic review and meta-analysis.
    BMJ. 2026;392:e085304.
    >> Share

  16. FALLOWS E
    Effective obesity care? Doctors could ask more about people's lives and less about their weight.
    BMJ. 2026;392:s1.
    >> Share

  17. DYER O
    Pill version of obesity jab is approved in US, with UK decision pending.
    BMJ. 2026;392:s2.
    >> Share

    December 2025
  18. SMUTNA T
    Government plans to tackle childhood obesity must follow Unicef's guidance.
    BMJ. 2025;391:r2542.
    >> Share

  19. TAYLOR L
    Obesity: WHO calls for increased production of Ozempic and other weight loss drugs.
    BMJ. 2025;391:r2540.
    >> Share

  20. MULVIHILL C, Parretti HM, Aswani N
    Overweight and obesity management: summary of updated NICE guidance.
    BMJ. 2025;391:r2286.
    >> Share

    November 2025
  21. LOGAN M
    Trump expands visa requirements to include diabetes and obesity.
    BMJ. 2025;391:r2400.
    >> Share

  22. BROWN C
    Trump strikes deal with Ozempic and Mounjaro makers to cut prices of obesity injections.
    BMJ. 2025;391:r2361.
    >> Share

  23. WISE J
    Obesity levels in schoolchildren at highest level outside pandemic.
    BMJ. 2025;391:r2346.
    >> Share

    October 2025
  24. COHEN JFW, Chapman LE, Schwartz MB
    The implications of the Make Our Children Healthy Again report for child health and obesity in the US.
    BMJ. 2025;391:r2116.
    >> Share

  25. NOLAN T
    Low dose oral semaglutide for obesity . . . and other research.
    BMJ. 2025;391:r2050.
    >> Share

    September 2025

  26. BMJ reports on the food industry, obesity services, and doctor suicide honoured at prestigious awards.
    BMJ. 2025;390:r1966.
    >> Share

  27. IACOBUCCI G
    Childhood obesity more common than underweight for first time in history, Unicef reports.
    BMJ. 2025;390:r1915.
    >> Share

  28. MAHASE E
    Energy drinks ban: Experts welcome government action for under 16s but question obesity claims.
    BMJ. 2025;390:r1862.
    >> Share

    August 2025
  29. BOWIE K
    Industry funded NHS obesity programme raises "significant" conflict of interest concerns.
    BMJ. 2025;390:r1793.
    >> Share

  30. LI B, Wetzel M, Ogweno S, Buse K, et al
    Neglecting obesity in the 2025 NCD agenda will leave one billion people behind.
    BMJ. 2025;390:r1693.
    >> Share

    July 2025
  31. ANSELMI ME, Ralston J, Axelrod S
    Obesity in Latin America: effective responses value lived experience.
    BMJ. 2025;390:r1211.
    >> Share

  32. HAGENAARS LL, Bero LA, van der Voorn B, Schmidt LA, et al
    Caution is prescribed for American Academy of Paediatrics' guidelines on weight loss medications for childhood obesity.
    BMJ. 2025;390:e084760.
    >> Share

    June 2025
  33. WISE J
    Obesity plan puts onus on supermarkets to promote healthy food.
    BMJ. 2025;389:r1361.
    >> Share

  34. RADA AG
    Spanish officials investigate Novo Nordisk's obesity awareness campaign.
    BMJ. 2025;389:r1319.
    >> Share

    May 2025
  35. MAHASE E
    New NHS obesity service to provide access to weight loss injections in Northern Ireland.
    BMJ. 2025;389:r1069.
    >> Share

  36. DELGADO C
    Obesity: can we cure our dependence on BMI?
    BMJ. 2025;389:r241.
    >> Share

  37. MOSCROP A, Dorling D, Cole TJ, Wright C, et al
    Child height figures show effects of covid, obesity, and inequality.
    BMJ. 2025;389:r917.
    >> Share

    April 2025
  38. MAHASE E
    Obesity: Concerns are raised over food industry's influence on government advisory board.
    BMJ. 2025;389:r674.
    >> Share

  39. OMENI-NZEWUIHE CC
    Tackling obesity: government must learn from failures in tobacco control.
    BMJ. 2025;389:r649.
    >> Share

    March 2025
  40. MYTTON OT, Campbell-Scherer D, Reckless I, Llewellyn C, et al
    Diagnosing and defining obesity.
    BMJ. 2025;388:r460.
    >> Share

  41. HUSE O, Sethi V, Rowel D, Shahula Ahmed A, et al
    Home, school, and retail food environments driving obesity among adolescent girls in South Asia.
    BMJ. 2025;388:e080359.
    >> Share

    February 2025
  42. O'DOWD A
    Wales to crack down on junk food promotions to tackle obesity.
    BMJ. 2025;388:r316.
    >> Share

  43. CARRON M, Tamburini E
    High flow nasal oxygenation in sedated gastrointestinal endoscopy for patients with obesity.
    BMJ. 2025;388:r184.
    >> Share

  44. WANG L, Zhang Y, Han D, Wei M, et al
    Effect of high flow nasal cannula oxygenation on incidence of hypoxia during sedated gastrointestinal endoscopy in patients with obesity: multicentre randomised controlled trial.
    BMJ. 2025;388:e080795.
    >> Share

    January 2025
  45. MAHASE E
    Obesity: Government accused of kicking problem "into the long grass" despite growing crisis.
    BMJ. 2025;388:r229.
    >> Share

  46. MAHASE E
    Obesity: Doctors should use "clinical judgment" to intervene if concerned about a child, NICE says.
    BMJ. 2025;388:r162.
    >> Share

  47. LANG K
    Can weight loss drugs like Ozempic treat obesity in children?
    BMJ. 2025;388:q2656.
    >> Share

  48. WATSON MC, Towers A
    Childhood obesity: positive change is possible.
    BMJ. 2025;388:r80.
    >> Share

  49. IACOBUCCI G
    Define obesity as clinical or pre-clinical for more accurate diagnosis, says global commission.
    BMJ. 2025;388:r78.
    >> Share

    December 2024
  50. FRANCO JVA, Manne-Goehler J
    GLP-1 receptor agonists and obesity care.
    BMJ. 2024;387:q2732.
    >> Share

  51. WISE J
    Tirzepatide: Obesity injection will get phased rollout to avoid overwhelming GPs.
    BMJ. 2024;387:q2744.
    >> Share

    November 2024
  52. IACOBUCCI G
    Childhood obesity in England's most deprived areas is double that in affluent areas.
    BMJ. 2024;387:q2457.
    >> Share

    October 2024
  53. WISE J
    Obesity: Peers call for total ban on junk food advertising.
    BMJ. 2024;387:q2329.
    >> Share

  54. LIMB M
    NHS England consults on rolling out obesity injection tirzepatide to meet demand.
    BMJ. 2024;387:q2180.
    >> Share

    September 2024
  55. IACOBUCCI G
    Junk food TV adverts to be banned before 9 pm to tackle childhood obesity.
    BMJ. 2024;386:q2006.
    >> Share

  56. MAHASE E
    Liraglutide: Weight loss injection is effective in children aged 6-11, study reports.
    BMJ. 2024;386:q1998.
    >> Share

  57. MAHASE E
    Obesity: Only half of England has access to comprehensive weight loss services.
    BMJ. 2024;386:q1950.
    >> Share

  58. MCLAUGHLIN J, Rejon CS, Bell M, Schwander B, et al
    Holistic modelling as a catalyst for effective obesity policy.
    BMJ. 2024;386:e077139.
    >> Share

  59. HOPTION CANN SA
    Tackling unhealthy food and obesity: teach children so they can teach their families.
    BMJ. 2024;386:q1925.
    >> Share

    August 2024
  60. GUENOT M
    How do GLP-1 drugs work for weight loss . . . and everything else?
    BMJ. 2024;386:q1767.
    >> Share

    July 2024
  61. BRIGGS A, Everest G
    Tackling unhealthy food and obesity: how far will the new Labour government go?
    BMJ. 2024;386:q1707.
    >> Share

  62. HAZLEHURST JM
    Obesity: time for NHS England to step up.
    BMJ. 2024;386:q1643.
    >> Share

  63. SALISBURY H
    Helen Salisbury: Weight loss treatment-available in theory but not in practice.
    BMJ. 2024;386:q1626.
    >> Share

  64. NOLAN T
    How do tirzepatide and semaglutide compare for weight loss ... and other research.
    BMJ. 2024;386:q1564.
    >> Share

    June 2024
  65. MAHASE E
    Obesity: Integrated care boards close lists for weight management services as demand skyrockets.
    BMJ. 2024;385:q1356.
    >> Share

  66. BUSE K, McKee M
    Obesity-a vital issue that's being overlooked in the UK elections.
    BMJ. 2024;385:q1378.
    >> Share

  67. WILKINSON E
    NICE recommendations on tirzepatide for weight loss could increase NHS access.
    BMJ. 2024;385:q1239.
    >> Share

    May 2024
  68. MAHASE E
    Semaglutide may provide sustained weight loss for at least four years, study reports.
    BMJ. 2024;385:q1113.
    >> Share

    April 2024
  69. WISE J
    NHS weight loss programme produces moderate benefit, analysis shows.
    BMJ. 2024;385:q930.
    >> Share

  70. PRATSIDES L
    The merits of an integrated approach to obesity treatment and prevention.
    BMJ. 2024;385:q822.
    >> Share

    March 2024
  71. HENDERSON K, Lewis, Sloan CE, Bessesen DH, et al
    Effectiveness and safety of drugs for obesity.
    BMJ. 2024;384:e072686.
    >> Share

  72. KOLKER C
    Chile passed tough measures to combat an obesity epidemic, so why does it still have an obesity problem?
    BMJ. 2024;384:q584.
    >> Share

  73. BUSE K, Ralston J, Barquera S
    Let's talk differently about obesity.
    BMJ. 2024;384:q537.
    >> Share

  74. TAYLOR L
    One in eight people globally are obese, with rates in children increasing fourfold in three decades.
    BMJ. 2024;384:q527.
    >> Share

    February 2024
  75. KMIETOWICZ Z
    Eating disorders: Targets fail to improve children's access to treatment, warn psychiatrists.
    BMJ. 2024;384:q523.
    >> Share

    January 2024
  76. MYTTON OT, Head V, Reckless I
    Public health perspective on new weight loss medications.
    BMJ. 2024;384:q196.
    >> Share

  77. MCNALLY S
    Scarlett McNally: Preventing obesity is different from curing it-and even more urgent.
    BMJ. 2024;384:q134.
    >> Share

    December 2023
  78. COURCOULAS AP, Daigle CR, Arterburn DE
    Long term outcomes of metabolic/bariatric surgery in adults.
    BMJ. 2023;383:e071027.
    >> Share

    November 2023
  79. IACOBUCCI G
    Challenges in diabetes and obesity: five minutes with . . . Jonathan Valabhji.
    BMJ. 2023;383:p2831.
    >> Share

    October 2023
  80. LADHER N, Hinton R, Veitch E
    Challenges of obesity and type 2 diabetes require more attention to food environment.
    BMJ. 2023;383:p2269.
    >> Share

  81. TOUVIER M, da Costa Louzada ML, Mozaffarian D, Baker P, et al
    Ultra-processed foods and cardiometabolic health: public health policies to reduce consumption cannot wait.
    BMJ. 2023;383:e075294.
    >> Share

  82. GHOSH TS, Valdes AM
    Evidence for clinical interventions targeting the gut microbiome in cardiometabolic disease.
    BMJ. 2023;383:e075180.
    >> Share

  83. MAESSEN SE, Nichols M, Cutfield W, Norris SA, et al
    High but decreasing prevalence of overweight in preschool children: encouragement for further action.
    BMJ. 2023;383:e075736.
    >> Share

    September 2023
  84. KMIETOWICZ Z
    Endoscopic sleeve gastroplasty can be used to treat obesity, says NICE.
    BMJ. 2023;382:p2240.
    >> Share

    August 2023
  85. MAHASE E
    Obesity: How long should drug treatment last?
    BMJ. 2023;382:p1772.
    >> Share

    June 2023
  86. TANNE JH
    Obesity: Avoid using BMI alone when evaluating patients, say US doctors' leaders.
    BMJ. 2023;381:1400.
    >> Share

  87. IACOBUCCI G
    NHS announces new specialist obesity clinics for children.
    BMJ. 2023;381:p1365.
    >> Share

    May 2023
  88. MULRENAN C, Jenner K, Knai C
    Tackling the obesity epidemic.
    BMJ. 2023;381:p1072.
    >> Share

  89. KMIETOWICZ Z
    Artificial sweeteners do not aid weight loss or improve health, says WHO.
    BMJ. 2023;381:p1112.
    >> Share

    April 2023
  90. WATSON MC, Lloyd J
    Obesogenic environments: the UK government needs to act now.
    BMJ. 2023;381:p940.
    >> Share

  91. KASSAM S
    Obesity: potatoes, pasta, and rice are not the problem.
    BMJ. 2023;381:p938.
    >> Share

  92. MAHASE E
    Obesity: Politicians' fears over "nanny-statism" have contributed to failed strategies, says report.
    BMJ. 2023;381:p900.
    >> Share

    March 2023
  93. WISE J
    Obesity conference ditches Nestle as sponsor after protests.
    BMJ. 2023;380:737.
    >> Share


  94. A call to the European Congress on Obesity: It's time to remove corporate sponsorship.
    BMJ. 2023;380:755.
    >> Share

  95. MCNALLY S
    Scarlett McNally: Obesity is a community issue, not just an individual one.
    BMJ. 2023;380:702.
    >> Share

  96. IACOBUCCI G
    Appetite suppressant semaglutide is to be made available to treat obesity in England.
    BMJ. 2023;380:p556.
    >> Share

  97. MAHASE E
    Global cost of overweight and obesity will hit $4.32tn a year by 2035, report warns.
    BMJ. 2023;380:p523.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016